Administration of recombinant activated factor VII in major thoracic operations.
Alavi
Ali-Asghar
AA
Jalali
Sayed Mahdi
SM
Rasouli
Mohammad R
MR
Eghtesadi-Araghi
Payam
P
D016063:Blood Loss, Surgical / Q000517:prevention & control*; D017558:Elective Surgical Procedures / Q000009:adverse effects / Q000379:methods; D015942:Factor VIIa / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011182:Postoperative Care / Q000379:methods; D019106:Postoperative Hemorrhage / Q000453:epidemiology / Q000517:prevention & control*; D011300:Preoperative Care / Q000379:methods; D011995:Recombination, Genetic; D012016:Reference Values; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D019616:Thoracic Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
D015942:Factor VIIa